Table of Contents

company-logo

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; KVD824, an oral product candidate for the treatment of HAE; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts.

KalVista Pharmaceuticals Dividend Announcement

• KalVista Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on KalVista Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

KalVista Pharmaceuticals Dividend History

KalVista Pharmaceuticals Dividend Yield

KalVista Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing KalVista Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

KalVista Pharmaceuticals Financial Ratios

P/E ratio-3.28
PEG ratio-0.24
P/B ratio2.69
ROE-97.37%
Payout ratio0.00%
Current ratio8.55
Quick ratio8.55
Cash Ratio1.42

KalVista Pharmaceuticals Dividend FAQ

Does KalVista Pharmaceuticals stock pay dividends?
KalVista Pharmaceuticals does not currently pay dividends to its shareholders.
Has KalVista Pharmaceuticals ever paid a dividend?
No, KalVista Pharmaceuticals has no a history of paying dividends to its shareholders. KalVista Pharmaceuticals is not known for its dividend payments.
Why doesn't KalVista Pharmaceuticals pay dividends?
There are several potential reasons why KalVista Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will KalVista Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While KalVista Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is KalVista Pharmaceuticals a dividend aristocrat?
KalVista Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is KalVista Pharmaceuticals a dividend king?
KalVista Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is KalVista Pharmaceuticals a dividend stock?
No, KalVista Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy KalVista Pharmaceuticals stocks?
To buy KalVista Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy KalVista Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.